| All Releases |
|---|
 |
Volcano Reports Record Quarterly Revenues and Profitability; Year-to-Date Revenues Increase 36 Percent
Jul 30, 2010
|
35.1 KB
|
| |
SAN DIEGO, July 30, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that revenues in the second quarter of 2010 increased 36 p...
|
|
|
Volcano Will Strongly Defend Against St. Jude Lawsuit
Jul 27, 2010
|
19.9 KB
|
| |
SAN DIEGO, July 27, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC) stated today that it will vigorously defend against the patent infringement lawsuit filed against it by St. Jude Medical in federal district court in Delaware. Volcano believes that the claims against it are entirely without merit, and looks forward ...
|
|
|
Volcano Corporation Schedules Second Quarter Conference Call, Webcast
Jul 20, 2010
|
19.5 KB
|
| |
SAN DIEGO, July 20, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will report its operating results for the sec...
|
|
|
Volcano Introduces VIBE(TM) RX - the World's Only Vascular Imaging Balloon Catheter
May 26, 2010
|
22.6 KB
|
| |
SAN DIEGO, May 26, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC) announced today that it has received CE Mark approval for the VIBE(TM) RX Vascular Imaging Balloon Catheter. The company also announced that it has completed its first clinical cases with the VIBE(TM) RX in New Zealand. A single VIBE(TM) RX Catheter c...
|
|
|
Volcano Announces Plans to Introduce Multiple New Products at EuroPCR 2010
May 24, 2010
|
23.2 KB
|
| |
SAN DIEGO, May 24, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC) announced today the company's plans to highlight its new product launches, presence in live cases, and participation in late breaking trials during EuroPCR from May 25 - 28 in Paris.
"Through both imaging and therapy, Volcano continues to lead the wa...
|
|
|
Volcano Announces Positive Clinical Experience With Its Second Generation OCT Catheter, Prepares for U.S. Regulatory Study
May 20, 2010
|
22.9 KB
|
| |
SAN DIEGO, May 20, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC) announced today the successful completion of Optical Coherence Tomography (OCT) cases with Volcano's second generation OCT catheter and system. Pending IDE approval, Volcano plans to use this OCT system in the US and South America as part of VOILA, a ...
|
|
|
Physicians Cite Positive First Clinical Experience with Volcano's Eagle Eye(R) Platinum Digital IVUS Catheter
May 20, 2010
|
22.5 KB
|
| |
SAN DIEGO, May 20, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC) announced today the completion of the first clinical cases using the new Eagle Eye(R) Platinum digital IVUS catheter. The procedures were performed in seven centers within the United States. Commercial launch of Eagle Eye(R) Platinum in the U.S. is ex...
|
|
|
Volcano Announces 510(k) Clearance, CE Mark Approval, and First Clinical Use for the PrimeWire PRESTIGE(TM) Pressure Guide Wire
May 19, 2010
|
23.4 KB
|
| |
SAN DIEGO, May 19, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC) announced today it received both 510(k) clearance and CE Mark approval for its PrimeWire PRESTIGE(TM) Pressure Guide Wire for use with patients who have both single-vessel and multi-vessel disease. This next generation pressure wire is compatible with...
|
|
|
Volcano Corporation Presentation at Bank of America Merrill Lynch Health Care Conference to Be Webcast
May 5, 2010
|
19.5 KB
|
| |
SAN DIEGO, May 5, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the Bank of America Merrill...
|
|
|
Volcano Reports 36 Percent Increase in First Quarter Revenues
May 3, 2010
|
29.0 KB
|
| |
SAN DIEGO, Calif., May 3, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that revenues for the first quarter of 2010 increase...
|
|
|
Volcano Announces Distribution Agreement With AngioScore for the AngioSculpt(R) PTCA Scoring Balloon Catheter in Japan
Apr 27, 2010
|
22.5 KB
|
| |
SAN DIEGO, April 27, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has entered into a distribution agreement wi...
|
|
|
Volcano Corporation Schedules First Quarter Conference Call, Webcast
Apr 26, 2010
|
19.4 KB
|
| |
SAN DIEGO, April 26, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will report its operating results for the fi...
|
|
|
Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems
Mar 12, 2010
|
21.9 KB
|
| |
SAN DIEGO, March 12, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today its Fractional Flow Reserve (FFR) technology can now...
|
|
|
Volcano Announces Activities at the ACC 2010
Mar 11, 2010
|
22.4 KB
|
| |
SAN DIEGO, Calif., March 11, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today its participation in the Annual Scientific S...
|
|
|
Volcano Corporation Presentation at Roth Capital Partners Conference to be Webcast
Mar 9, 2010
|
19.4 KB
|
| |
SAN DIEGO, March 9, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the 22nd Annual Roth OC G...
|
|
|
Volcano Reports 44 Percent Increase in Fourth Quarter Revenues
Mar 3, 2010
|
35.5 KB
|
| |
SAN DIEGO, March 3, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that revenues for the quarter ended December 31, 2009, wer...
|
|
|
Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
Feb 24, 2010
|
19.4 KB
|
| |
SAN DIEGO, Feb 24, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will report its operating results for the fou...
|
|
|
Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter
Feb 9, 2010
|
22.3 KB
|
| |
SAN DIEGO, Feb 09, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has received 510(k) clearance from the U.S. F...
|
|
|
Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter
Feb 9, 2010
|
23.6 KB
|
| |
SAN DIEGO, Feb 09, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract(TM) Thrombus Aspirati...
|
|
|
Volcano Corporation Announces Litigation Status
Feb 5, 2010
|
19.6 KB
|
| |
SAN DIEGO, Feb 05, 2010 /PRNewswire via COMTEX News Network/ -- Volcano Corporation (Nasdaq: VOLC) today announced that the jury in the litigation filed by Lightlab Imaging, Inc. on January 7, 2009 in the Superior Court of Massachusetts, Suffolk County reached a verdict against Volcano and its wholly owned subsidiary, Axsun Technologies. In Decem...
|
|
|
